Breakthrough ALS study launches as drug aims to slow disease progression
Top Story
•
April 3, 2026
•
0 Views
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
Source: https://feeds.feedburner.com/foxnews/latest - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
